EGM
PACB icon

Engineers Gate Manager’s Pacific Biosciences PACB Stock Holding History

Engineers Gate Manager’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.1K Sell
45,320
-6,969
-13% -$10.1K ﹤0.01% 2095
2026
Q1 		$69K Buy
52,289
+30,818
+144% +$55.1K ﹤0.01% 2063
2025
Q4 		$40.2K Buy
+21,471
New +$41.3K ﹤0.01% 1995
2025
Q3 		– Sell
-88,827
Closed -$110K – 2432
2025
Q2 		$110K Buy
+88,827
New +$103K ﹤0.01% 1982
2024
Q3 		– Sell
-102,260
Closed -$140K – 2322
2024
Q2 		$140K Sell
102,260
-195,611
-66% -$395K ﹤0.01% 1701
2024
Q1 		$1.12M Buy
297,871
+277,071
+1,332% +$1.62M 0.03% 762
2023
Q4 		$204K Buy
+20,800
New +$170K 0.01% 1634
2022
Q2 		– Sell
-402,217
Closed -$3.66M – 2161
2022
Q1 		$3.66M Buy
402,217
+389,169
+2,983% +$4.48M 0.14% 155
2021
Q4 		$267K Sell
13,048
-11,619
-47% -$280K 0.01% 1478
2021
Q3 		$630K Sell
24,667
-21,711
-47% -$643K 0.04% 744
2021
Q2 		$1.62M Buy
+46,378
New +$1.35M 0.1% 237
2021
Q1 		– Sell
-13,370
Closed -$347K – 2049
2020
Q4 		$347K Sell
13,370
-18,251
-58% -$310K 0.02% 1202
2020
Q3 		$312K Sell
31,621
-9,538
-23% -$54.9K 0.01% 1229
2020
Q2 		$142K Buy
41,159
+8,703
+27% +$29.6K 0.01% 1518
2020
Q1 		$99K Sell
32,456
-149,407
-82% -$612K 0.01% 1416
2019
Q4 		$935K Sell
181,863
-8,296
-4% -$42.2K 0.04% 678
2019
Q3 		$981K Buy
+190,159
New +$1.06M 0.05% 546
2018
Q4 		– Sell
-165,321
Closed -$894K – 1064
2018
Q3 		$894K Buy
+165,321
New +$709K 0.07% 372

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Engineers Gate Manager's PACB Position: Q2 2026 in Review

Engineers Gate Manager reduced its Pacific Biosciences (PACB) stake by 13% in Q2 2026, selling an estimated $10.1K and leaving 45,320 shares worth $76.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Engineers Gate Manager first reported a position in PACB in Q3 2018 and has held it in 18 quarters since. The position peaked at $3.66M in Q1 2022. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Engineers Gate Manager held 45,320 shares of Pacific Biosciences worth $76.1K as of Q2 2026.
  • Engineers Gate Manager sold 6,969 Pacific Biosciences shares in Q2 2026, an estimated $10.1K.
  • Pacific Biosciences made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2095 holding.
  • Engineers Gate Manager first reported a position in Pacific Biosciences in Q3 2018 and has held it in 18 quarters since.
  • Engineers Gate Manager's Pacific Biosciences position peaked at $3.66M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.